The DOI matches its Crossref record; 72 of the 74 references it cites were found in a registry or an index, and 2 are not checked yet.
Macrophage PPARγ is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones
Open accessAbstract
PPAR gamma is required for fat cell development and is the molecular target of antidiabetic thiazolidinediones (TZDs), which exert insulin-sensitizing effects in adipose tissue, skeletal muscle, and liver. Unexpectedly, we found that inactivation of PPAR gamma in macrophages results in the development of significant glucose intolerance plus skeletal muscle and hepatic insulin resistance in lean mice fed a normal diet. This phenotype was associated with increased expression of inflammatory markers and impaired insulin signaling in adipose tissue, muscle, and liver. PPAR gamma-deficient macrophages secreted elevated levels of factors that impair insulin responsiveness in muscle cells in a manner that was enhanced by exposure to FFAs. Consistent with this, the relative degree of insulin resistance became more severe in mice lacking macrophage PPAR gamma following high-fat feeding, and these mice were only partially responsive to TZD treatment. These findings reveal an essential role of PPAR gamma in macrophages for the maintenance of whole-body insulin action and in mediating the antidiabetic actions of TZDs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Studies in PPARγ deficient mice exhibit impaired M2 macrophage function and susceptibility to diet-induced inflammation and insulin resistance [29,65–67].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [66]
In the citing paper
“thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
In the citing paper
“Treatment of macrophages with the insulin-sensitizing drugs thiazolidinediones (TZDs), which are PPARγ ligands, polarizes macrophages toward the M2/antiinflammatory state, thus providing a potential mechanism by which activation of macrophage PPARγ reduces inflammation and enhances insulin sensitivity (106).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [106]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Mechanisms of fatty acid-induced inhibition of glucose uptake.
Boden, G., Chen, X., Ruiz, J., White, J. V., & Rossetti, L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117252 · Cited by 3,720
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,645
The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J., & Glass, C. K. (1998) · Nature · doi:10.1038/34178 · Cited by 3,525
Self-citation
Flagged first, then by citations
Research works printed but not linked: 3
- Ibrahimi, 1994, Mol. Pharmacol., 46, 1070
- 10.1172/JCI200525102 · DOI · Paper page
- 10.1172/JCI200419528 · DOI
Cited by
Sorted by citations
Items 301–400 of 457
Dopaminergic Pathways in Obesity-Associated Inflammation
Leite, F., & Ribeiro, L. V. P. T. (2019) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-019-09863-0 · Cited by 34
Obesity, Systemic Hypertension, and Pulmonary Hypertension: A Tale of Three Diseases
Wahab, A., Dey, A. K., Bandyopadhyay, D., Katikineni, V. S., Chopra, R., Vedantam, K., Devraj, M., Chowdary, A. K., Navarengom, K., Lavie, C. J., et al. (2020) · Current Problems in Cardiology · doi:10.1016/j.cpcardiol.2020.100599 · Cited by 31
Obesity, Inflammation, and Insulin Resistance
Ellies, L. G., Johnson, A., & Olefsky, J. M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6819-6_1 · Cited by 31
Self-citationNamgaladze, D., Kemmerer, M., von Knethen, A., & Brüne, B. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt073 · Cited by 30
Sharma, S., Sharma, P. M., Mistry, D. S., Chang, R. J., Olefsky, J. M., Mellon, P. L., & Webster, N. J. G. (2010) · Biology of Reproduction · doi:10.1095/biolreprod.110.088005 · Cited by 30
Self-citationThe diverse roles of macrophages in metabolic inflammation and its resolution
Ray, A. G., Odum, O., Wiseman, D., & Weinstock, A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1147434 · Cited by 31
Hashimoto, O., & Funaba, M. (2011) · Vitamins and hormones · doi:10.1016/b978-0-12-385961-7.00011-1 · Cited by 29
Cho, Y. M., Kim, D. H., Lee, K. H., Jeong, S., & Kwon, O. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0131-0 · Cited by 28
Hommelberg, P. P. H., LANGEN, R. C. J., Schols, A. M. W. J., Mensink, R. P., & Plat, J. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32833f1acd · Cited by 29
Nuclear receptor mediated mechanisms of macrophage cholesterol metabolism
Nagy, Z. S., Czimmerer, Z., & Nagy, L. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.04.003 · Cited by 27
FADD is a key regulator of lipid metabolism
Zhuang, H., Wang, X., Zha, D., Gan, Z., Cai, F., Du, P., Yang, Y., Yang, B., Zhang, X., Yao, C., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505924 · Cited by 27
Wang, T., Villegas, S., Huang, Y., White, S. K., Ahlem, C. N., Lu, M. M., Olefsky, J. M., Reading, C. L., Frincke, J. M., Alleva, D. G., et al. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.161182 · Cited by 27
Self-citationIRF6 Regulates Alternative Activation by Suppressing PPARγ in Male Murine Macrophages
Li, C., Ying, W., Huang, Z., Brehm, T. J., Morin, A., Vella, A. T., & Zhou, B. (2017) · Endocrinology · doi:10.1210/en.2017-00053 · Cited by 26
Enteral glutamine: a novel mediator of PPARγ in the postischemic gut
Ban, K., & Kozar, R. A. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107764 · Cited by 25
Wang, X.-A., Deng, S., Jiang, D., Zhang, R., Zhang, S., Zhong, J., Li, Y., Wang, T., Hong, S., Guo, S., et al. (2013) · Endocrinology · doi:10.1210/en.2012-1911 · Cited by 25
TNF-alpha modulates adipose macrophage polarization to M1 phenotype in response to scorpion venom
Ait‐Lounis, A., & Laraba‐Djebari, F. (2015) · Inflammation Research · doi:10.1007/s00011-015-0876-z · Cited by 25
Hu, S., Yao, J., Howe, A. A., Menke, B. M., Sivitz, W. I., Spector, A. A., & Norris, A. W. (2012) · Molecular Endocrinology · doi:10.1210/me.2011-1253 · Cited by 25
Weber, K., Sauer, M. A., He, L., Tycksen, E., Kalugotla, G., Razani, B., & Schilling, J. D. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800224 · Cited by 24
Maternal Immunization Affects In Utero Programming of Insulin Resistance and Type 2 Diabetes
Eberle, C., Merki, E., Yamashita, T., Johnson, S., Armando, A. M., Quehenberger, O., Claudio Napoli, A., & Palinski, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045361 · Cited by 26
The Role of Skeletal Muscle Estrogen Receptors in Metabolic Homeostasis and Insulin Sensitivity
Hevener, A. L., Zhou, Z., Drew, B. G., & Ribas, V. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-70178-3_13 · Cited by 23
Self-citationMeng, F., Hao, P., & Du, H. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17680 · Cited by 21
Inflammation‐mediated obesity and insulin resistance as targets for nutraceuticals
Kim, M., Lee, M. S., & Kwon, D.-Y. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06098.x · Cited by 23
Chen, H., Dardik, B. N., Qiu, L., Ren, X., Caplan, S. L., Burkey, B. F., Boettcher, B. R., & Gromada, J. (2010) · Endocrinology · doi:10.1210/en.2009-1366 · Cited by 22
Innate immune cells for immunotherapy of autoimmune and cancer disorders
Schäfer, C., Ascui, G., Ribeiro, C. H., López, M. N., Prados‐Rosales, R., González, P. A., Bueno, S. M., Riedel, C. A., Baena, A., Kalergis, A. M., et al. (2017) · International Reviews of Immunology · doi:10.1080/08830185.2017.1365145 · Cited by 22
Zeng, Z., Yu, B., Mao, X., & Chen, D. (2011) · Meat Science · doi:10.1016/j.meatsci.2011.06.004 · Cited by 22
Maciejewska, A., Massidda, M., Tocco, F., & Leźnicka, K. (2022) · Nutrients · doi:10.3390/nu14245378 · Cited by 23
Pott, S., Kamrani, N. K., Bourque, G., Pettersson, S., & Liu, E. T. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048102 · Cited by 21
Ban, K., Sprunt, J. M., Martin, S. J., Yang, P., & Kozar, R. A. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00174.2011 · Cited by 21
Local activation of the IκK-NF-κB pathway in muscle does not cause insulin resistance
Polkinghorne, E., Lau, Q., Cooney, G. J., Kraegen, E. W., & Cleasby, M. E. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00537.2007 · Cited by 21
Kakazu, E., Kondo, Y., Ninomiya, M., Kimura, O. S., Nagasaki, F., Ueno, Y., & Shimosegawa, T. (2012) · Hepatology International · doi:10.1007/s12072-012-9395-y · Cited by 19
Cell‐specific insulin resistance: implications for atherosclerosis
Rajwani, A., Cubbon, R. M., & Wheatcroft, S. B. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2336 · Cited by 20
Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?
Pap, A., Cuaranta‐Monroy, I., Peloquin, M., & Nagy, L. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17081236 · Cited by 20
Celestrin, C. P., Rocha, G. Z., Stein, A. M., Guadagnini, D., Tadelle, R. M., Saad, M. J. A., & Oliveira, A. G. (2020) · European Review of Aging and Physical Activity · doi:10.1186/s11556-020-00244-8 · Cited by 22
Takaya, T., Wada, H., Morimoto, T., Sunagawa, Y., Kawamura, T., Takanabe‐Mori, R., Shimatsu, A., Fujita, Y., Sato, Y., Fujita, M., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0488 · Cited by 20
Duan, S., Usher, M. G., Foley, E. L., Milstone, D. S., Brosius, F. C., & Mortensen, R. M. (2010) · Diabetologia · doi:10.1007/s00125-010-1748-2 · Cited by 20
Re-highlighting the action of PPARγ in treating metabolic diseases
Choi, S. H., Chung, S. S., & Park, K. S. (2018) · F1000Research · doi:10.12688/f1000research.14136.1 · Cited by 19
Zhao, Q., Yu, Z., Zhang, S., Shen, X.-R., Yang, H., Xu, Y., Liu, Y., Yang, L., Zhang, Q., Chen, J., et al. (2022) · iScience · doi:10.1016/j.isci.2022.105319 · Cited by 19
Davies, N. A., Watkeys, L. J., Butcher, L., Potter, S., Hughes, M. G., Moir, H. J., Morris, K., Thomas, A. W., & Webb, R. (2014) · Free Radical Research · doi:10.3109/10715762.2014.978311 · Cited by 18
Shen, Z., Yang, Q.-Z., Li, C., Du, L., Sun, X., Liu, Y., Sun, J., Gu, H.-H., Sun, Y.-M., Wang, J., et al. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.05.005 · Cited by 18
Pirzgalska, R. M., & Domingos, A. I. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.04.014 · Cited by 18
Carey, A. L., Siebel, A. L., Reddy-Luthmoodoo, M., Natoli, A. K., D’Souza, W., Meikle, P. J., Sviridov, D., Drew, B. G., & Kingwell, B. A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056601 · Cited by 18
Blood glucose regulation in context of infection
Wensveen, F. M., Šestan, M., Wensveen, T. T., & Polić, B. (2021) · Vitamins and hormones · doi:10.1016/bs.vh.2021.06.009 · Cited by 20
Insights Into Macrophage Polarization and M1 / M2 Balance in Diabetic Foot Ulcers
Zhang, J., Li, H., Dong, Y., Zhou, Z., Wang, Y., Chen, X., & Cai, Y. (2026) · Journal of Diabetes · doi:10.1111/1753-0407.70205 · Cited by 18
The role of cytokines in the regulation of drug disposition: extended functional pleiotropism?
Liptrott, N. J., & Owen, A. (2011) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2011.553600 · Cited by 16
Jürets, A., Itariu, B. K., Keindl, M., Prager, G., Langer, F. B., Grablowitz, V., Zeyda, M., & Stulnig, T. M. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2477-5 · Cited by 17
Blaszczak, A. M., Wright, V. P., Anandani, K., Liu, J., Jalilvand, A., Bergin, S. M., Nicoloro, S. M. C., Czech, M., Lafuse, W. P., Deng, T., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801470 · Cited by 16
Lifestyle and Food Habits Impact on Chronic Diseases: Roles of PPARs
d’Angelo, M., Castelli, V., Tupone, M. G., Catanesi, M., Antonosante, A., Dominguez-Benot, R., Ippoliti, R., Cimini, A., & Benedetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215422 · Cited by 17
Cuaranta‐Monroy, I., Kiss, M., Simándi, Z., & Nagy, L. (2015) · European Journal of Clinical Investigation · doi:10.1111/eci.12491 · Cited by 15
Kim, S., Kim, Y., & Oh, Y. (2021) · Annals of Eye Science · doi:10.21037/aes-21-4 · Cited by 14
Zorrilla, S., Garzón, B. S., & Pérez‐Sala, D. (2009) · Analytical Biochemistry · doi:10.1016/j.ab.2009.12.021 · Cited by 15
Wang, F., Sun, J., Huang, M., Wang, H., Sun, P., Lin, J., & Chen, W. (2013) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2013.10.074 · Cited by 15
Huang, Z., Niu, R. D., Xu, Q., Zhang, R., Hu, W., Qin, Y., Wang, X., Xu, Q., Xia, Y., Fan, Y., et al. (2025) · Environmental Health Perspectives · doi:10.1289/ehp14888 · Cited by 15
Macrophages: friend or foe in diabetes pathogenesis and therapy
Grimes, R. N., Orecchioni, M., & Quesada‐Masachs, E. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1625391 · Cited by 15
Yun, N., Nah, J., Lee, M. N., Wu, D., & Pae, M. (2023) · Nutrients · doi:10.3390/nu15112617 · Cited by 14
Mitonuclear Communication in Stem Cell Function
Peng, B., Wang, Y., & Zhang, H. (2024) · Cell Proliferation · doi:10.1111/cpr.13796 · Cited by 14
Signalling Networks Governing Metabolic Inflammation
Dali‐Youcef, N., & Ricci, R. (2015) · Handbook of experimental pharmacology · doi:10.1007/164_2015_4 · Cited by 14
Kai, M., Miyoshi, M., Fujiwara, M., Nishiyama, Y., Inoue, T., Maeshige, N., Hamada, Y., & Usami, M. (2016) · Journal of Surgical Research · doi:10.1016/j.jss.2016.11.048 · Cited by 14
Lee, M., Ryu, H., Van, J. Y., Kim, M., Jeong, H. H., Jung, W., Jun, J. Y., & Lee, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411467 · Cited by 13
Jing, X., Ou, C., Chen, H., Wang, T., Xu, B., Lu, S.-F., & Zhu, B. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/8098561 · Cited by 13
Pioglitazone: More than just an insulin sensitizer # †
Czaja, M. J. (2009) · Hepatology · doi:10.1002/hep.22983 · Cited by 13
Effect of Chronic Pioglitazone Treatment on Hepatic Gene Expression Profile in Obese C57BL/6J Mice
Jia, C., Huan, Y., Liu, S., Hou, S., Sun, S., Li, C., Liu, Q., Jiang, Q., Wang, Y., & Shen, Z. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160612213 · Cited by 12
Adipose inflammation: cause or consequence of obesity-related insulin resistance
Xu, H. (2008) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s4180 · Cited by 12
Pascual, G., Ricote, M., & Hevener, A. L. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1503 · Cited by 12
Self-citationLiu, D., Morales, F. E., IglayReger, H. B., Treutelaar, M. K., Rothberg, A. E., Hubal, M. J., Nadler, E. P., Robidoux, J., Barakat, H. A., Horowitz, J. F., et al. (2017) · Applied Physiology Nutrition and Metabolism · doi:10.1139/apnm-2017-0228 · Cited by 11
Pathways Involved In Lipid-Induced Insulin Resistance In Obesity
Watt, M. J., & Steinberg, G. R. (2007) · Future Lipidology · doi:10.2217/17460875.2.6.659 · Cited by 11
Self-citationPPARγ mutations, lipodystrophy and diabetes
Astapova, O., & Leff, T. (2014) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2014-0033 · Cited by 11
The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy
Treacy, M. P., & Hurst, T. P. (2012) · BMC Ophthalmology · doi:10.1186/1471-2415-12-46 · Cited by 11
Naturally improving insulin resistance with amorfrutins
Lefèbvre, P., & Staels, B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204455109 · Cited by 11
Schwanstecher, C., & Schwanstecher, M. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_1 · Cited by 11
Ninni, A., Zaccaria, F., Verteramo, L., Sciarretta, F., Silveira, L. S., Neto, J. C. R., Carotti, S., Nevi, L., Grumati, P., Patel, S., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60295-2 · Cited by 11
Lu, Y., Jia, Y., Lü, J., Liu, J., Xu, Y., Liu, Y., & Chen, K. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1991957 · Cited by 10
Adipose Tissue T Regulatory Cells: Implications for Health and Disease
Bradley, D. P., Shantaram, D., Smith, A. J., & Hsueh, W. A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_8 · Cited by 10
A New Role for Cyclic Phosphatidic Acid as a PPARγ Antagonist
Tanaka, Y., & Glass, C. K. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.08.010 · Cited by 10
Self-citationEffects of rosiglitazone on intramyocellular lipid accumulation in Psammomys obesus
Molero, J. C., Lee, S., Leizerman, I., Chajut, A., Cooper, A., & Walder, K. R. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.10.002 · Cited by 10
Alternative macrophage activation and the regulation of metabolism
Webb, P. (2009) · F1000 Biology Reports · doi:10.3410/b1-2 · Cited by 9
Estradiol replacement improves high‐fat diet‐induced insulin resistance in ovariectomized rats
Yokota‐Nakagi, N., Omoto, S., Tazumi, S., Kawakami, M., Takamata, A., & Morimoto, K. (2022) · Physiological Reports · doi:10.14814/phy2.15193 · Cited by 9
Tseng, H.-T., Park, Y. J., Lee, Y., & Moore, D. D. (2015) · Journal of Biomedical Science · doi:10.1186/s12929-015-0133-3 · Cited by 9
A Novel Mathematical Model Detecting Early Individual Changes of Insulin Resistance
Eberle, C., Palinski, W., & Ament, C. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0084 · Cited by 9
Wu, X., Zhang, J., Ge, H., Gupte, J., Baribault, H., Lee, K. J., Lemon, B. D., Coberly, S. K., Gong, Y., Pan, Z., et al. (2015) · EBioMedicine · doi:10.1016/j.ebiom.2015.02.013 · Cited by 9
Leukocyte set points in metabolic disease
Odegaard, J. I., & Chawla, A. (2012) · F1000 Biology Reports · doi:10.3410/b4-13 · Cited by 9
Obesity and muscle‐macrophage crosstalk in humans and mice: A systematic review
Rudrapatna, S., Bhatt, M., Wang, K., Bierbrier, R., Wang, P., Banfield, L. E., Elsheikh, W., Sims, E. D., Peterson, D. C., Thabane, L., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12922 · Cited by 9
Ustianowski, P., Malinowski, D., Safranow, K., Dziedziejko, V., Tarnowski, M., & Pawlik, A. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12020243 · Cited by 8
Zhou, Z., Moore, T. M., Strumwasser, A. R., Ribas, V., Iwasaki, H., Morrow, N., Ma, A., Tran, P. H., Wanagat, J., Vallim, T. Q. D. A., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102116 · Cited by 9
Self-citationPPARδ Agonism for the Treatment of Obesity and Associated Disorders: Challenges and Opportunities
Perreault, M., Erbe, D. V., & Tobin, J. F. (2008) · PPAR Research · doi:10.1155/2008/125387 · Cited by 9
Macrophage Polarization and Inflammation at the Interface of Cardiovascular Disease and Metabolism
Shen, Z., Lu, M., Duan, S., & Duan, S. (2011) · North American Journal of Medicine and Science · doi:10.7156/v4i4p191 · Cited by 7
Molecular Genetics of Metabolic Syndrome
Chang, Y., Yu, Y., & Chuang, L. (2013) · Wiley eBooks · doi:10.1002/9780470015902.a0024320 · Cited by 7
Li, J., Li, C., Zhao, Y., Wu, X., Yu, S., Sun, G., Ding, P., Si, L., Zhang, L., Yang, P., et al. (2022) · Scientific Reports · doi:10.1038/s41598-024-75055-3 · Cited by 11
De, S., Banerjee, S., Rakshit, P., Banerjee, S., & Kumar, S. K. A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998291968240429111357 · Cited by 6
Etiopathogenesis of insulin resistance
Gupta, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820234-0.00010-x · Cited by 7
Nuclear receptor control of opposing macrophage phenotypes in cardiovascular disease
Frieler, R. A. (2011) · Frontiers in bioscience · doi:10.2741/4028 · Cited by 6
Bhatt, M., Rudrapatna, S., Banfield, L. E., Bierbrier, R., Wang, P., Wang, K.-W., Thabane, L., & Samaan, M. C. (2017) · BMC Research Notes · doi:10.1186/s13104-017-2686-6 · Cited by 6
Hamano, Y., Okude, T., Yokosuka, O., & Ogawa, M. (2011) · Nephron Extra · doi:10.1159/000331704 · Cited by 6
Insulin downregulates C3 gene expression in human HepG2 cells through activation of PPARγ
Shavva, V. S., Bogomolova, A. M., Efremov, A. M., Трофимов, А. Н., Nikitin, A. A., Babina, A. V., Nekrasova, E. V., Dizhe, E. B., Oleinikova, G. N., Missyul, B. V., et al. (2018) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2018.03.001 · Cited by 6
Nanocarriers to mediate the pathways from diabetes toward Parkinson's disease
De, S., & Kuo, Y. (2024) · Journal of the Taiwan Institute of Chemical Engineers · doi:10.1016/j.jtice.2024.105401 · Cited by 6
Chen, Y.-Q., Shao, Y.-C., & Wei, R.-L. (2024) · Journal of Lipid Research · doi:10.1016/j.jlr.2024.100606 · Cited by 5
[Study on relationship between human ABO blood groups and type A behavior pattern].
Mao, X., Xu, M., Mu, S., Ma, Y., & He, M. (1991) · PubMed · Cited by 5
ElHady, S. A., Abd‐Elmawla, M. A., Shamaa, M. M., & Abdelgawad, H. M. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.109156 · Cited by 4
Karsikas, S. (2015) · Cited by 4
PPARs: Important Regulators in Metabolism and Inflammation
Sanderson, L. M., & Kersten, S. (2010) · Springer eBooks · doi:10.1007/978-90-481-3303-1_10 · Cited by 4
The relationship of lipid imbalance and chronic inflammation mediated by PPAR
Čavojský, T., Bilka, F., & Paulíková, I. (2016) · Česká a slovenská farmacie · doi:10.36290/csf.2016.001 · Cited by 4
Metadata
- Authors
- Hevener, A. L., Olefsky, J. M., Reichart, D., Nguyen, M. T. A., Bandyopadyhay, G., Leung, H.-Y., Watt, M. J., Benner, C., Febbraio, M. A., Nguyen, A.-K., Folian, B., Subramaniam, S., Gonzalez, F. J., Glass, C. K., & Ricote, M.
- Affiliations
- University of California San Diego (US)
- University of California System (US)
- The University of Melbourne (AU)
- Baker Heart and Diabetes Institute (AU)
- National Institutes of Health (US)
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-06-01
- Volume
- 117
- Issue
- 6
- Pages
- 1658-1669
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1868788
- OpenAlex
- W2131598118
- Cited by
- 459
- References
- 71
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 9 · 2022: 10 · 2021: 10 · 2020: 13 · 2019: 17 · 2018: 23 · 2017: 22 · 2016: 18 · 2015: 28 · 2014: 32 · 2013: 49 · 2012: 41
- FWCI
- 16.31
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- Pfizer
- Takeda Pharmaceutical Company
- Ministerio de Economía y Competitividad
- National Institutes of Health (DK 074868, DK-063491, GM-069338)
- University of California, San Diego (DK063491)
- National Heart, Lung, and Blood Institute (P50HL056989, HL-56989)
- National Institute of General Medical Sciences (U54GM069338, GM 069338)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK063491, DK 074868, DK 60484, DK-33651, K01DK060484, R37DK033651, R21DK073227, P01DK074868, DK73227, R01DK033651, P30DK063491)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PPARγ, macrophages, thiazolidinediones, insulin resistance, insulin sensitivity, skeletal muscle, liver, adipose tissue, impaired glucose tolerance, inflammation, insulin signaling, fatty acids, high-fat diet, antidiabetic drugs
- MeSH terms
- Animals, Base Sequence, Hypoglycemic Agents, Insulin Resistance, Liver, Macrophages, Mice, Transgenic, Promoter Regions, Genetic, Adipocytes, DNA Primers, Mice, Knockout, Muscle, Skeletal, Gene Expression Profiling, Thiazolidinediones, PPAR gamma, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review